Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Check out some of our latest original content that was created and distributed as part of our ongoing collaborations with IR firms and other companies.

SuperCom Ltd. (NASDAQ: SPCB) Continues Expansion of National Public Safety EM Contracts

Posted on February 27, 2025 by MissionIR
  • Electronic monitoring (“EM”) technology developer SuperCom has developed a full range of best-in-class technology products and accompanying services to help criminal justice agencies reduce recidivism and incarceration costs while increasing rehabilitation potential for offenders
  • The company recently reported a new contract win, its seventh domestic violence EM project on a national level
  • In addition to national contract expansion throughout Europe, SuperCom has reported 20 new EM contracts throughout the United States
  • Market analysts have noted the growing call for EM products and services, with marked increased usage in North America, Latin America, and Europe in recent years, underscoring SuperCom’s continued growth

SuperCom (NASDAQ: SPCB), a company specializing in electronic monitoring (“EM”) technology to help public safety agencies reduce the incidence of repeated domestic violence (“DV”), is announcing a new EM contract win that expands its portfolio of national DV monitoring projects.

The use of EM technology as an alternative to incarceration has been increasing on a global scale since public safety agencies in the United States began working with it in the 1980s. Last year, market analysts at ResearchAndMarkets.com and Berg Insight both reported that the number of participants in EM programs reached about 518,000 in North America, 130,000 in Latin America, and 64,000 in Europe during 2023 (https://ibn.fm/dZEL2).

The analysts forecast the number of participants in these EM programs will increase to about 680,000 in North America, 239,000 in Latin America, and 94,000 in Europe by 2028, underscoring the rising pace of new participants as government officials seek the means for cutting prison system costs while continuing to ensure the safety of their communities.

Overall, Berg reported that by the end of 2023, nearly 1.4 million people had participated in an EM supervision program, with nearly two-thirds of them in the United States (https://ibn.fm/BR3VF). SuperCom’s latest contract brings its current list of national EM of DV projects to seven, including announced services for the state police of Latvia (https://ibn.fm/eDQds) and Romania’s Ministry of Interior (https://ibn.fm/S7O7k).

The company noted it is outpacing its competitors with its expansion and is demonstrating its reputation as a leader in providing DV monitoring solutions. In addition to its large ongoing European expansion, SuperCom has signed 20 new contracts for technological solutions throughout the United States since last August, including services in six states where SuperCom’s products are being used for the first time (https://ibn.fm/VpDhJ).

The company also notes the technology’s potential for reducing recidivism (repeated offenses) by helping suspects and convicted offenders who qualify for EM monitoring to return to everyday work, school, and home activities while wearing a tech device that is discreet and easily recharged.

“We are pleased to see another national government choose our DV advanced electronic monitoring solutions, demonstrating the strong trust governments place in our technology and their satisfaction with its effectiveness,” SuperCom President and CEO Ordan Trabelsi stated in the company’s most recent announcement. “SuperCom continues to strengthen its position as a trusted partner for government agencies seeking effective, scalable solutions for public safety. With each new deployment, we help authorities enhance victim protection and offender compliance, driving real impact in communities.”

SuperCom uses both radio frequency (“RF”) and GPS, the dominant technologies in the EM market, to provide at-home and on-the-street supervision of offenders by the criminal justice system, which is suited to clients’ needs.

The company’s advanced PureTrack GPS platform includes branded technology elements such as the wearable bracelets PureOne (GPS) and the PureTag (RFID), the home base station PureCom, and the PureProtect mobile app.

SuperCom has a track record of more than 50 government clients served, monitoring more than 100,000 individuals.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
[email protected]

MissionIR is powered by IBN

Posted in SuperCom Ltd. SPCB | Leave a comment

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), Viridi Partner on Buffalo, NY Solar and Battery Project

Posted on February 26, 2025 by MissionIR
  • SolarBank and Viridi are collaborating on a 3.06 MW solar and 1.2 MWh battery energy storage system in Buffalo, New York, repurposing a closed landfill, converting unused land into a source of clean energy.
  • Pending approvals and financing, SolarBank is set to begin construction, while Viridi will provide the battery storage system.
  • Viridi’s battery systems include integrated fire suppression and anti-propagation technology to enhance safety.
  • Once operational, the project will function under a community solar model, where residents can subscribe to the project, earning credits on their electricity bills without installing personal solar panels.

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., has announced a partnership with Viridi, the industry leader in fail-safe battery energy storage systems (“BESS”), to develop a combined 3.06 megawatt (“MW”) direct current ground-mounted solar power project and a 1.2 megawatt-hour (“MWh”) BESS, in Buffalo, New York. This initiative aims to transform a closed landfill into a productive asset that generates clean energy for the local community (https://ibn.fm/XEmgk).

The selected site, located at 1037 South Park Ave. in South Buffalo, was previously a landfill. By repurposing this land, the project not only addresses environmental concerns but also contributes to the community by providing a sustainable energy source. This approach exemplifies innovative land use, turning otherwise unusable areas into hubs for renewable energy production.

Once operational, the project will function under a community solar model. This setup allows local residents, including renters and homeowners, to subscribe to the solar project. Subscribers receive credits on their electricity bills corresponding to their share of the generated solar energy, enabling them to benefit from renewable energy without the need to install personal solar panels. This model promotes inclusivity and broad participation in clean energy initiatives.

Viridi, known for its leadership in fail-safe battery energy storage systems, will supply the BESS for this project. Their innovative lithium-ion battery packs are equipped with integrated fire suppression and pioneering anti-propagation technology. Unlike traditional methods that modify battery cells, Viridi’s design isolates each cell to prevent thermal runaway, ensuring that a single cell failure does not escalate. This fail-safe approach enhances safety and reliability, making the energy storage solution adaptable for various settings.

SolarBank, subject to the receipt of financing, intends to be the owner of the project. The company has secured a lease for the project site and has applied for interconnection approval. Upon receiving the necessary permits and financing, the company plans to commence construction. The integration of the BESS with the solar installation will allow for the storage of generated energy, which can be dispatched during peak demand periods, thereby enhancing grid stability and optimizing energy use. This project aligns with New York State’s energy storage roadmap, which supports the development of such hybrid generation-storage projects.

SolarBank has already begun construction on another BESS project, representing the company’s first foray into this sector. The company has kicked off construction of project SFF-06, one out of two battery energy storage systems in Ontario, earlier in February 2025, through a $25.8 million CAD ($18.17 million USD) project finance facility from the Royal Bank of Canada. The initiatives come as battery storage demand surges, with the global market projected to reach $31.2 billion USD by 2029, growing at 16.3% annually (https://ibn.fm/G6g5b).

For more information, visit the company’s website at SolarBankCorp.com. This report contains forward looking information. Please refer to https://ibn.fm/G76GJ for additional details.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
[email protected]

MissionIR is powered by IBN

Posted in SolarBank Corp. SUUN | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Joins Sourcewell Contract for Government EV Purchases

Posted on February 26, 2025 by MissionIR

Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, announced that its all-electric commercial vehicles, the Mullen ONE Class 1 EV cargo van and Mullen THREE Class 3 EV cab chassis truck, have been added to National Auto Fleet Group’s (NAFG) Sourcewell contract. This approval allows government agencies and educational institutions to purchase Mullen’s commercial EVs through NAFG without lengthy bidding procedures. Sourcewell, a government agency that streamlines procurement, offers competitively solicited contracts, making fleet acquisition more efficient. NAFG, a California-based dealer, is also an approved California Air Resource Board (“CARB”) HVIP dealer, enabling significant incentives on the Mullen THREE, including up to $45,000 in cash vouchers and a $7,500 federal tax credit, potentially reducing its cost to under $17,000.

To view the full press release, visit https://ibn.fm/IfRsf

About Mullen Automotive Inc.

Mullen Automotive is a Southern California-based automotive company building the next generation of commercial electric vehicles (“EVs”) with two United States-based vehicle plants located in Tunica, Mississippi, (120,000 square feet) and Mishawaka, Indiana (650,000 square feet). In August 2023, Mullen began commercial vehicle production in Tunica. In September 2023, Mullen received IRS approval for federal EV tax credits on its commercial vehicles with a Qualified Manufacturer designation that offers eligible customers up to $7,500 per vehicle. As of January 2024, both the Mullen ONE, a Class 1 EV cargo van, and Mullen THREE, a Class 3 EV cab chassis truck, are California Air Resource Board (“CARB”) and EPA certified and available for sale in the U.S. The CARB-issued HVIP approval on the Mullen THREE, Class 3 EV truck, provides up to a $45,000 cash voucher at time of vehicle purchase. The company has also recently expanded its commercial dealer network to seven dealers with the addition of Papé Kenworth. Other previously announced dealers include Pritchard EV, National Auto Fleet Group, Ziegler Truck Group, Range Truck Group, Eco Auto, and Randy Marion Auto Group, providing sales and service coverage in key Midwest, West Coast, Pacific Northwest, New England and Mid-Atlantic markets. The company has also announced Foreign Trade Zone (“FTZ”) status approval for its Tunica, Mississippi, commercial vehicle manufacturing center. FTZ approval provides a number of benefits, including deferment of duties owed and elimination of duties on exported vehicles. For more information about the company, visit www.MullenUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to MULN are available in the company’s newsroom at https://ibn.fm/MULN

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in Mullen Automotive Inc. MULN | Leave a comment

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Drives Growth with Strengthened Financial Position and Cutting-Edge Research

Posted on February 25, 2025 by MissionIR
  • One of the most significant challenges facing biotechnology companies is securing adequate funding to sustain research and development efforts.
  • Calidi’s improved financial footing reassures investors and allows the company to focus on achieving key milestones in its research pipeline.
  • The company has been selected to present new data on its RTNova systemic virotherapy platform at the prestigious AACR annual meeting in April 2025.

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company, is making significant strides in the field of cancer immunotherapy. Known for its innovative approach to antitumor virotherapies, Calidi is focused on harnessing the power of its patented technology that protects and potentiates the virotherapy during administration (extracellular enveloped viruses in its systemic platform and stem cells in its intratumoral platforms) to target and destroy cancer cells while simultaneously stimulating the immune system. The company’s groundbreaking work has positioned it as a leader in the development of next-generation cancer treatments.

In recent news, Calidi has made two major announcements that underscore its progress, one related to its strengthened financial position and another highlighting its acceptance into a prestigious scientific seminar to present new research. These developments signal the company’s growth and its continued advancement toward commercializing its therapies.

One of the most significant challenges facing biotechnology companies is securing adequate funding to sustain research and development efforts. Calidi Biotherapeutics recently announced that it has strengthened its financial position, ensuring continued progress in its clinical and preclinical programs (https://ibn.fm/9JicX). As of Dec. 31, 2024, Calidi reported a cash balance of approximately $9.6 million. This increase is largely due to successful fundraising efforts, including proceeds from the company’s At-the-Market Offering Agreement (“ATM”).

As a result of these efforts, Calidi was able to terminate its Standby Equity Purchase Agreement (“SEPA”) with YA II PN Ltd., an affiliate of Yorkville Advisors, effective Jan. 23, 2025. The infusion of capital will allow the company to further refine its oncolytic virotherapy platforms, expand its clinical trials, and enhance its overall operational stability.

Additionally, Calidi announced the successful closing of a public offering on Jan. 10, 2025, which raised an additional $4.25 million in gross proceeds. This contributes to the ongoing development of Calidi’s proprietary technologies and supports the company’s mission to bring effective cancer therapies to market. This improved financial footing not only reassures investors but also allows Calidi to focus on achieving key milestones in its research pipeline. With adequate funding in place, the company is well-positioned to continue its groundbreaking work in cancer immunotherapy.

Beyond its financial achievements, Calidi Biotherapeutics has also made headlines for its acceptance into a major scientific conference where it will present its latest research findings (https://ibn.fm/WZ1RO). The company announced that it has been selected to present new data on its RTNova systemic virotherapy platform at the prestigious American Association for Cancer Research (“AACR”) annual meeting in April 2025.

This recognition marks an important milestone for Calidi, as the AACR annual meeting is one of the most influential conferences in the field of cancer research. Being accepted to present at this event underscores the significance of Calidi’s work and its potential to revolutionize cancer treatment.

Calidi’s RTNova platform is designed to overcome the limitations of traditional virotherapy by enabling systemic delivery and enhancing the targeting of metastatic tumors. Antitumor virotherapies have long been recognized for their ability to selectively infect and kill cancer cells, but challenges such as immune system clearance and limited distribution have hindered their full potential. The RTNova platform addresses these challenges by utilizing an extracellular enveloped virus (“EEV”) as a delivery mechanism, allowing the therapeutic viruses to reach tumors more effectively while evading premature destruction by the immune system. These preclinical findings highlight the RTNova platform’s ability to effectively target and treat metastatic cancer cells and represent a significant advancement in the field of cancer virotherapy.

In addition to the RTNova platform, Calidi is actively developing other innovative therapies aimed at harnessing the immune system to combat cancer. The company’s approach to immunotherapy focuses on protecting the viral payload to enhance the efficacy of antitumor viruses, potentially improving outcomes for patients with hard-to-treat cancers.

With a strengthened financial position and the recognition of its research by a leading scientific organization, Calidi Biotherapeutics is poised for continued growth. The company’s ability to secure funding ensures that it can maintain momentum in its clinical and preclinical programs, while its acceptance into a high-profile scientific seminar validates the importance of its work. As Calidi moves forward, it is well-positioned to make a lasting impact in the biotechnology industry. With continued innovation and a strong financial foundation, the company is set to play a crucial role in the future of cancer immunotherapy.

For more information, visit www.CalidiBio.com.

NOTE TO INVESTORS: The latest news and updates relating to CLDI are available in the company’s newsroom at https://ibn.fm/CLDI

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
[email protected]

MissionIR is powered by IBN

Posted in Calidi Biotherapeutics Inc. CLDI | Leave a comment

MissionIRNewsBreaks – GivBux Inc. (GBUX) Approves Special Dividend Warrant Issuance

Posted on February 25, 2025 by MissionIR

GivBux (OTC: GBUX) announced that its Board of Directors approved a special dividend for shareholders in the form of warrants, authorizing a 1-for-10 warrant issuance that will allow the purchase of additional common stock at a price to be determined later. The dividend underscores the company’s commitment to rewarding loyal shareholders and enabling participation in future growth as it scales its Super App platform globally, said President Umesh Tim Singh. Pricing details and the warrant exercise period will be provided in future communications.

To view the full press release, visit https://ibn.fm/oB172

About GivBux Inc.

The GivBux Super App revolutionizes shopping by offering a user-friendly tool to make purchases swiftly and easily at more than 100 national retailers, along with an expanding roster of local merchants. Users earn cash back on every purchase, a portion of which can be directed toward a charity of their choice, embodying GivBux’s commitment to “give back.” The GivBux Super App is free to use and available now. The GivBux Super App is constantly evolving and adding new enhancements and functionalities, including social networking, e-commerce, banking, messaging, food delivery and transportation. GivBux is forging a new path in e-commerce and charitable giving and aspires to build the largest community of givers, initially in the United States and eventually worldwide. To learn more about the company, visit www.GivBux.com.

NOTE TO INVESTORS: The latest news and updates relating to GBUX are available in the company’s newsroom at https://ibn.fm/GBUX

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in GivBux Inc. GBUX | Leave a comment

MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Partners with APST Research to Advance ALS Drug Approval Process

Posted on February 25, 2025 by MissionIR

Clene (NASDAQ: CLNN) has entered into an agreement with Germany-based APST Research GmbH to utilize its extensive neurofilament light chain (NfL) database in FDA-recommended analyses of CNM-Au8® for treating amyotrophic lateral sclerosis (ALS). APST’s repository includes biomarker data from over 4,300 ALS patients, which will help Clene compare NfL changes in NIH-sponsored Expanded Access Protocol participants to matched controls. The results could support Clene’s planned New Drug Application submission for CNM-Au8 under the FDA’s Accelerated Approval pathway in the second half of 2025. CEO Rob Etherington emphasized the importance of leveraging real-world evidence to advance potential treatments for ALS.

To view the full press release, visit https://ibn.fm/YgZeb

About Clene Inc.

Clene (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease and multiple sclerosis. CNM-Au8® is an investigational first-in-class therapy that improves central nervous system cells’ survival and function via a mechanism that targets mitochondrial function and the NAD pathway while reducing oxidative stress. CNM-Au8® is a federally registered trademark of Clene Nanomedicine, Inc. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland. For more information, please visit www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in Clene Inc. CLNN | Leave a comment

MissionIRNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), Viridi Collaborate on Hybrid Generation Solar Project in Buffalo

Posted on February 24, 2025 by MissionIR

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), an independent renewable and clean energy project developer and owner focusing on distributed and community solar projects in Canada and the U.S., was featured in an article published by Buffalo Business First. The piece highlights SolarBank’s collaboration with Viridi on a proposed $7 billion solar project at a former landfill in South Buffalo, which would include 3.06 megawatts of solar generation and 1.2 megawatt-hours of battery storage. While relatively rare, these hybrid generation projects are becoming more common according to Matthew McGregor, senior developer of U.S. business development at Solarbank, citing New York’s adoption of its energy storage roadmap. McGregor also spoke of money-making opportunities for the operator having on-site battery storage at a solar farm.

To view the full article, visit https://ibn.fm/YVFDK

About SolarBank Corporation

SolarBank Corporation is an independent renewable and clean energy project developer and owner focusing on distributed and community solar projects in Canada and the USA. The company develops solar, battery energy storage system (“BESS”) and EV charging projects that sell electricity to utilities, commercial, industrial, municipal and residential off-takers. The company maximizes returns via a diverse portfolio of projects across multiple leading North America markets including projects with utilities, host off-takers, community solar, and virtual net metering projects. The company has a potential development pipeline of over one gigawatt and has developed renewable and clean energy projects with a combined capacity of over 100 megawatts built.

For more information, visit the company’s website at SolarBankCorp.com. This report contains forward looking information. Please refer to https://ibn.fm/G76GJ for additional details.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

Third-Party Content

The MIR website may contain Third-Party Content articles and other content submitted by third parties, including articles submitted through the MIR Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions MIR or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and MIR does not endorse, guarantee or make representations concerning the accuracy and completeness of any third-party content. You acknowledge that by MIR providing you with this internet portal that makes accessible to you the ability to view third party content through the MIR site, MIR does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. MIR expressly disclaims liability relating to such third-party content. MIR and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, MIR reserves the right to remove third-party content at any time in its sole discretion. By viewing this third-party content, you acknowledge that you have viewed, read fully, accepted and agreed to all terms of the Disclaimer at https://www.missionir.com/disclaimer.html

The disclaimers on the MIR website are applicable to all content provided by MIR, wherever published or re-published are at: https://www.missionir.com/disclaimer.html

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in SolarBank Corp. SUUN | Leave a comment

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Sees Growth, Potential in Oncology Drug Development, a Critical Frontier in Cancer Treatment

Posted on February 24, 2025 by MissionIR
  • According to the American Cancer Society, cancer is the second leading cause of death globally.
  • Oncology drugs are a cornerstone of modern cancer treatment.
  • Calidi Biotherapeutics is a cutting-edge biotechnology company dedicated to developing innovative cancer treatments.

Cancer continues to be one of the most significant health challenges of our time, with its global impact growing every year. The increasing number of cancer diagnoses and related deaths underscores the urgent need for more effective treatments, including advanced oncology drugs. Companies such as Calidi Biotherapeutics (NYSE American: CLDI) are at the forefront of research and development, offering hope for millions of patients worldwide.

According to the American Cancer Society, cancer is the second leading cause of death globally, with 2,001,140 new cancer cases and 611,720 cancer deaths projected to occur in the United States in 2024 (https://ibn.fm/JA0DN). Approximately one in six deaths worldwide is due to cancer. The global cancer burden is expected to rise to 28.4 million cases by 2040, a 47% increase from 2020. This surge is driven by population growth, aging, and lifestyle factors such as tobacco use, poor diet, and physical inactivity.

Among the most prevalent and deadly forms of cancer are lung cancer, which is responsible for 1.8 million deaths annually, making it the leading cause of cancer-related mortality (https://ibn.fm/woQzB); colorectal cancer, which accounts for nearly 935,000 deaths each year (https://ibn.fm/ms7ty); breast cancer, the most commonly diagnosed cancer, with more than 2.3 million new cases annually (https://ibn.fm/O313h); and stomach and liver cancers, which account for approximately 968,784 (https://ibn.fm/zyWfM) and 866,136 deaths per year, respectively (https://ibn.fm/4EvTp).

These statistics highlight the enormous need for effective cancer treatments, especially for high-mortality cancers such as glioblastoma (“GBM”), triple-negative breast cancer (“TNBC”), sarcoma and certain types of lung cancer.

Oncology drugs are a cornerstone of modern cancer treatment. These drugs range from traditional chemotherapy to targeted therapies and immunotherapies, which aim to enhance the body’s immune response against cancer cells. Oncology drugs play a vital role in:

  • Extending Survival: Many advanced therapies have significantly improved survival rates for cancers once considered untreatable.
  • Improving Quality of Life: Targeted treatments and immunotherapies often come with fewer side effects than traditional chemotherapy, allowing patients to maintain a better quality of life.
  • Personalized Medicine: Advances in genetic testing have enabled the development of personalized oncology drugs tailored to the unique genetic makeup of a patient’s tumor.

The global oncology drug market was valued at approximately $158 billion in 2022 and is projected to reach $327 billion by 2037, reflecting a compound annual growth rate (“CAGR”) of 7.5% (https://ibn.fm/xBVyH). However, despite these advances, significant gaps remain in treatment efficacy, accessibility, and affordability, underscoring the urgent need for continued innovation.

Calidi Biotherapeutics is a cutting-edge biotechnology company dedicated to developing innovative cancer treatments. Their unique approach leverages antitumor virotherapies and patented technologies designed to protect and potentiate the virotherapy during administration to combat cancer more effectively and with fewer side effects. Calidi’s therapeutic strategy centers on harnessing the power of antitumor virotherapies, which are engineered to selectively infect and destroy cancer cells while sparing healthy tissue.

To enhance the delivery and efficacy of these viruses, Calidi uses extracellular enveloped viruses in its systemic platform and stem cells in its intratumoral platforms to protect the virotherapy from the body’s immune system during administration. The company’s dual approach offers multiple advantages, including targeted tumor destruction, in which viruses directly attack cancer cells, leading to their destruction; and immune system activation, a process that triggers a systemic immune response and trains the immune system to recognize and attack cancer cells throughout the body.

Calidi’s robust pipeline includes three key product candidates:

  • RTNova (“CLD-400”): Targeting lung cancer and metastatic cancer, RTNova is a systemic platform that can be administered intravenously. The technology includes a vaccinia virus enveloped with a human cell membrane designed to protect the viral payload from the body’s immune system during administration and home in on cancer cells.
  • SuperNova (“CLD-201”): Targeting solid tumors such as head and neck, triple-negative breast cancer and soft tissue sarcoma, SuperNova combines mesenchymal stem cells with vaccinia viruses. This therapy aims to overcome the limitations of traditional treatments by directly targeting tumors and activating the immune system.
  • NeuroNova (“CLD-101”): This therapy is designed for patients with glioblastoma and other high-grade gliomas. It utilizes neural stem cells to deliver antitumor viruses directly to brain tumors, offering a promising new approach for one of the most aggressive and treatment-resistant cancers.

Calidi is also developing next-generation engineered antitumor viruses to broaden the scope of cancers treatable with its platform.

The groundbreaking work being done by Calidi Biotherapeutics has the potential to transform the oncology drug market and significantly improve cancer care. By focusing on high-need cancer types such as GBM, TNBC, sarcoma and lung cancer, Calidi addresses critical gaps in current treatment options. The company’s innovative therapies not only aim to improve survival rates but also reduce the debilitating side effects associated with many existing cancer treatments. As Calidi’s products advance through clinical trials, they hold the promise of offering new hope to patients facing some of the most challenging cancers.

The global burden of cancer continues to grow, making the need for effective oncology drugs more pressing than ever. As a leader in innovative cancer treatment, Calidi Biotherapeutics is poised to play a pivotal role in shaping the future of oncology drug development. Its pioneering therapies represent a new frontier in the fight against cancer, offering hope for improved outcomes and a better quality of life for millions of patients worldwide.

For more information, visit www.CalidiBio.com.

NOTE TO INVESTORS: The latest news and updates relating to CLDI are available in the company’s newsroom at https://ibn.fm/CLDI

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
[email protected]

MissionIR is powered by IBN

Posted in Calidi Biotherapeutics Inc. CLDI | Leave a comment

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Reports Substantial Revenue, Gross Profit Growth, with Key Developments Painting Positive Outlook

Posted on February 24, 2025 by MissionIR
  • The company’s six-month revenue reached $20.1 million CAD ($14.15 million USD), reflecting steady long-term growth despite seasonal fluctuations.
  • Gross profit margin increased to 29.2%, up from 18.4% in the prior year, signaling improved margins.
  • Assets surged 372% to $185.3 million CAD ($130.47 million USD) during the six month period, following the acquisition of Solar Flow-Through Funds Ltd.
  • Recent $70.3 million CAD ($49.5 million USD) deal with Qcells will drive revenue in upcoming quarters.
  • Share price more than doubled in early February, signaling investor interest.

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., posted its fiscal 2025 second-quarter results, emphasizing its six-month revenue of $20.1 million CAD ($14.15 million USD) and improved gross margins. According to the Q2 results, the company’s gross profit rose to $5.9 million CAD ($4.15 million USD) (or 29.2% of revenues), from $4.8 million CAD ($3.38 million USD) in 2024, reflecting a shift toward higher-margin business lines (https://ibn.fm/F30Jw).

Additionally, independent power producer (“IPP”) revenue increased from CAD $0.14 million ($0.07 million USD) to $5.4 million CAD ($3.8 million USD) during the same six-month period, with assets growing 372% to $185.3 million CAD ($130.47 million USD) following the acquisition of Solar Flow-Through Funds Ltd., as compared to $39.2 million CAD ($27.6 million USD) on June 30, 2024. The company ended the second quarter of fiscal 2025 with $33.6 million CAD ($23.66 million USD) in current assets, as compared to $17.6 million CAD ($12.39 million USD) in current assets as of year-end June 30, 2024. The increase is principally the result of the closing of the Solar Flow-Through Funds acquisition.

In addition to the encouraging Q2 results, the company’s stock saw a sharp rally in early February, rising from $3.86 CAD ($2.72 USD) on Jan. 31 to $9.08 CAD ($6.39 USD) by Feb. 10. While the price has since stabilized, the spike suggests growing investor interest in the company’s strategic direction and upcoming projects (https://ibn.fm/ZiPvC).

Beyond the current financials report, SolarBank is positioning itself for sustained expansion moving forward, recently securing additional major financing and strategic partnerships:

  • $70.3 million CAD ($49.5 million USD) transaction with Qcells to sell and construct four solar projects in New York, with revenues to be recognized in future quarters (https://ibn.fm/QOyJY). The projects will utilize high-quality Qcells modules that will be manufactured in the U.S. The deal is part of the nearly $2.8 billion USD being invested by Qcells to boost U.S. domestic solar manufacturing and innovation to support and accelerate the U.S. clean energy transition.
  • $25.8 million CAD ($18.17 million USD) project finance facility from RBC to develop two battery energy storage systems (“BESS”) in Ontario, a sector with strong long-term growth potential. Representing the company’s first foray into the battery storage sector, construction on the first project, SFF-06, began during the Feb. 10 week (https://ibn.fm/5WEhQ).
  • 145 MW of solar projects in the pipeline, expected to reach notice to proceed within the next 12 months.

These projects reinforce SolarBank’s focus on securing stable, recurring revenue streams, including independent power production.

CEO Richard Lu acknowledged that seasonal factors affected Q2 revenue, a common trend in the solar industry, especially in winter months. However, higher-margin power production and asset growth offset the slight decline, leading to improved overall gross profits. “This is stable recurring revenue that is under long-term contracts, and we will continue to grow this business as evidenced by the $25.8 million Royal Bank of Canada debt facility that supports the construction of the BESS projects that we own,” Lu said.

The CEO also pointed out that delays in EPC (engineering, procurement, and construction) revenue were expected, as the company focused on securing a strong development partner. The Qcells deal, finalized at the end of the quarter, means these revenues will now be reflected in the coming periods, he added.

SolarBank’s strong asset growth, rising profit margins, and new revenue streams from power production and storage projects position the company well for continued success. With a robust project pipeline and investor interest reflected in the recent stock price rally, SolarBank sees itself well-positioned for sustained growth in the renewable energy market.

For more information, visit the company’s website at SolarBankCorp.com. This report contains forward looking information. Please refer to https://finance.yahoo.com/news/solarbank-announces-second-quarter-results-120000457.html and the press release referenced in this article for additional details on the nature, assumptions and risk factors associated with this forward looking information.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
[email protected]

MissionIR is powered by IBN

Posted in SolarBank Corp. SUUN | Leave a comment

MissionIRNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Paving Way in Its ‘Vision for the Future of Digital Finance’

Posted on February 21, 2025 by MissionIR

Thumzup (NASDAQ: TZUP), an emerging leader in social media branding and marketing solutions, recently doubled its Bitcoin (“BTC”) investment from $1 to $2 million. “This brings its BTC holdings to 19.106 in a move that looks to increase the company’s exposure to Bitcoin while also demonstrating its commitment to diversifying treasury assets and capitalizing on the potential of digital assets,” reads a recent article. “Earlier in the year, Thumzup’s Board of Directors authorized the allocation of up to 90% of the company’s surprise cash to be held in Bitcoin. This aligned with the company’s Treasury Asset Strategy that was announced on Nov. 15, 2024. ‘We see Bitcoin not only as a strategic asset for treasury management but also as a fundamental component of our vision for the future of digital finance,’ noted Robert Steele, Thumzup’s CEO. ‘This investment reflects our confidence in Bitcoin’s role as a store of value and its potential to reshape global financial markets.’”

To view the full article, visit https://ibn.fm/Dc0gL

About Thumzup®
Thumzup Media Corporation is democratizing the multi-billion dollar social media branding and marketing industry. Its flagship product, the Thumzup platform, utilizes a robust programmatic advertiser dashboard coupled with a consumer-facing App to enable individuals to get paid cash for posting about participating advertisers on major social media outlets through the Thumzup App. The easy-to-use dashboard allows advertisers to programmatically customize their campaigns. Cash payments are made to App users/creators through PayPal and other digital payment systems.

Thumzup was featured on CBS Los Angeles and in KTLA.

NOTE TO INVESTORS: The latest news and updates relating to TZUP are available in the company’s newsroom at https://ibn.fm/TZUP

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in Thumzup Media Corp. TZUP | Leave a comment